Artiva Biotherapeutics, Inc. Common Stock
ARTV
$7.29+3.70%
Delayed · as of Sep 30, 2026, 12:16 PM ET
Mkt cap
$37.28M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-3.23
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Use this ARTV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARTV income, balance, and cash tables.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company in the Healthcare sector.
Latest cached Artiva Biotherapeutics, Inc. Common Stock (ARTV) net income for Dec 31, 2025 was -$83.9M. Statements: https://lician.com/financials/artv
Artiva Biotherapeutics, Inc. Common Stock (ARTV) market capitalization is $37.3M on the latest cached snapshot.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) cached previous close $7.03; day range $6.96 – $7.39; volume 95,314. Session quote: https://lician.com/quote/artv
Artiva Biotherapeutics, Inc. Common Stock (ARTV) latest cached earnings event is "ARTV earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARTV filing is 8-K · Sep 11, 2026. Filings: https://lician.com/sec/artv